French doctors shine light on deadly cancer in bold combo treatment trial
NCT ID NCT02662504
Summary
This study tested whether a complex, multi-step treatment plan is safe and feasible for people with a serious chest cancer called malignant pleural mesothelioma. Six patients received surgery to remove visible tumor, followed immediately by a special light-activated drug therapy inside the chest cavity. After surgery, they also received standard chemotherapy and radiation. The main goal was to see if patients could complete this entire intensive plan without severe side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT PLEURAL MESOTHELIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU de Lille Hôpital Calmette
Lille, France
Conditions
Explore the condition pages connected to this study.